JPMorgan Chase & Co. on NBIX, Oct 15, 2026

JPMorgan Chase & Co. now owns 5.2%, as a passive investor.

Date
Oct 15, 2026
Who
JPMorgan Chase & Co.
Fund
NBIX - Neurocrine Biosciences
Stake
5.2% (5,300,390 shares)
Type of notice
Updated notice
Document number
0000019617-26-000371

Open the original document at the SEC →

We read this document automatically. If something looks wrong, the original is the one that counts.

Back to NBIX